The summary below is from the full report titled Should Immunoglobulin Therapy Be Used in Allogeneic Stem-Cell Transplantation? A Randomized, Double-Blind, Dose Effect, Placebo-Controlled, Multicenter Trial. It is in the 1 July 2003 issue of Annals of Internal Medicine (volume 139, pages 8-18). The authors are C. Cordonnier, S. Chevret, M. Legrand, H. Rafi, N. Dhdin, B. Lehmann, F. Bassompierre, and E. Gluckman, for the GREFIG Study Group.
Immunoglobulin in Patients with Stem-Cell Transplants. Ann Intern Med. 2003;139:I–45. doi: https://doi.org/10.7326/0003-4819-139-1-200307010-00002
Download citation file:
Published: Ann Intern Med. 2003;139(1):I-45.
Interstitial Lung Disease, Prevention/Screening, Pulmonary/Critical Care.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use